128 related articles for article (PubMed ID: 7713397)
1. ARCAD: a method for estimating age-dependent disease risk associated with mutation carrier status from family data.
Le Bihan C; Moutou C; Brugières L; Feunteun J; Bonaïti-Pellié C
Genet Epidemiol; 1995; 12(1):13-25. PubMed ID: 7713397
[TBL] [Abstract][Full Text] [Related]
2. A method for estimating cancer risk in p53 mutation carriers.
Le Bihan C; Bonaiti-Pellie C
Cancer Detect Prev; 1994; 18(3):171-8. PubMed ID: 8076379
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
4. Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset.
Carayol J; Bonaïti-Pellié C
Genet Epidemiol; 2004 Sep; 27(2):109-17. PubMed ID: 15305327
[TBL] [Abstract][Full Text] [Related]
5. Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer.
Brugières L; Gardes M; Moutou C; Chompret A; Meresse V; Martin A; Poisson N; Flamant F; Bonaïti-Pellié C; Lemerle J
Cancer Res; 1993 Feb; 53(3):452-5. PubMed ID: 8425176
[TBL] [Abstract][Full Text] [Related]
6. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
Nichols KE; Malkin D; Garber JE; Fraumeni JF; Li FP
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):83-7. PubMed ID: 11219776
[TBL] [Abstract][Full Text] [Related]
7. [Li-Fraumeni syndrome].
Frebourg T
Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
[TBL] [Abstract][Full Text] [Related]
8. Follow-up study of twenty-four families with Li-Fraumeni syndrome.
Garber JE; Goldstein AM; Kantor AF; Dreyfus MG; Fraumeni JF; Li FP
Cancer Res; 1991 Nov; 51(22):6094-7. PubMed ID: 1933872
[TBL] [Abstract][Full Text] [Related]
9. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
[TBL] [Abstract][Full Text] [Related]
10. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM
Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816
[TBL] [Abstract][Full Text] [Related]
11. Estimating disease risk associated with mutated genes in family-based designs.
Choi YH; Kopciuk KA; Briollais L
Hum Hered; 2008; 66(4):238-51. PubMed ID: 18612208
[TBL] [Abstract][Full Text] [Related]
12. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
13. Estimating cancer risk in HNPCC by the GRL method.
Alarcon F; Lasset C; Carayol J; Bonadona V; Perdry H; Desseigne F; Wang Q; Bonaïti-Pellié C
Eur J Hum Genet; 2007 Aug; 15(8):831-6. PubMed ID: 17473834
[TBL] [Abstract][Full Text] [Related]
14. Correcting for ascertainment bias of relative-risk estimates obtained using affected-sib-pair linkage data.
Cordell HJ; Olson JM
Genet Epidemiol; 2000 Apr; 18(4):307-21. PubMed ID: 10797591
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
Birch JM; Hartley AL; Tricker KJ; Prosser J; Condie A; Kelsey AM; Harris M; Jones PH; Binchy A; Crowther D
Cancer Res; 1994 Mar; 54(5):1298-304. PubMed ID: 8118819
[TBL] [Abstract][Full Text] [Related]
16. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.
Lalloo F; Varley J; Moran A; Ellis D; O'dair L; Pharoah P; Antoniou A; Hartley R; Shenton A; Seal S; Bulman B; Howell A; Evans DG
Eur J Cancer; 2006 May; 42(8):1143-50. PubMed ID: 16644204
[TBL] [Abstract][Full Text] [Related]
17. [When is it useful to look for TP53 germline gene mutations in families of oncology patients?].
Trková M; Sedlácek Z
Cas Lek Cesk; 2003; 142(4):220-5. PubMed ID: 12841124
[TBL] [Abstract][Full Text] [Related]
18. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392
[TBL] [Abstract][Full Text] [Related]
19. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.
Tabori U; Nanda S; Druker H; Lees J; Malkin D
Cancer Res; 2007 Feb; 67(4):1415-8. PubMed ID: 17308077
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of susceptibility to breast cancer.
Hulka BS
Prog Clin Biol Res; 1996; 395():159-74. PubMed ID: 8895988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
